TrialX
Image

PGTai Results for Embryos Cultured in Sequential Versus Single Step Media

PGTai Results for Embryos Cultured in Sequential Versus Single Step Media

Recruiting
18-37 years
All
Phase N/A

Overview

A prospective cohort study undergoing ICSI at a private fertility center in Egypt

Description

Purpose

To evaluate PGTai results for embryos cultured in sequential versus single step media.

Method

Injected oocytes will divided between Continuous Single Culture-NX media (CSC- NX) with 10% SSS the first group (Irvine, USA) and the other group will be cultured in sequential cleavage and blastocyst media with 10% SPS (SAGE, Denmark).

All blastocytes with 4BB quality and better according to Gardner's criteria 1999 will go through PGTA procedures with PGTai confirmation.

Eligibility

Inclusion Criteria:

  • Female age 37 years with 8 mature oocytes
  • Male partner had normal semen parameters according to WHO 2010
  • PGT-A was done at the blastocyst stage

Exclusion Criteria:

  • sperm or oocyte donor
  • severe male factors according to WHO 2010

Study details
    Mosaicism
    Female Genital Diseases
    Infertility
    Infertility
    Aneuploidy Rate

NCT04485910

Ganin Fertility Center

5 August 2020

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.